Vienna, Austria

Akos Szakmary

This inventor holds 5 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignee: University of California. Active years: 2016-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Akos Szakmary. Retrieved from https://idiyas.com/inventor/akos-szakmary

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 40.0


 

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2016-2023

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Journey of Inventor Akos Szakmary

Introduction:

Akos Szakmary is a prolific inventor based in Vienna, Austria, who has made significant contributions to the field of hematopoietic stem cell (HSC) transplantation. With a total of five patents to his name, he is known for his groundbreaking work in developing radiation-free methods for HSC transplantation.

Latest Patents:

His latest patents showcase his pioneering approach to HSC transplantation. One of his notable inventions is the "Method for Chemoselection," which involves administering purine base analogs to subjects undergoing HSC transplantation without the need for radiation pre-conditioning. This method not only eliminates the toxic effects of myeloablative radiation but also ensures successful engraftment of donor HSCs.

Career Highlights:

Akos Szakmary is associated with the prestigious University of California, where he continues to push the boundaries of medical innovation. His expertise in the field of stem cell research has earned him recognition among his peers and industry experts alike. Szakmary's dedication to developing safer and more effective treatment protocols has the potential to revolutionize the field of regenerative medicine.

Collaborations:

In his pursuit of scientific excellence, Akos Szakmary collaborates closely with fellow researchers and experts in the field. Notable colleagues include Noriyuki Kasahara and Robert H Schiestl, who share his passion for advancing the understanding of hematopoietic stem cell biology and transplantation techniques. Through these collaborations, Szakmary has been able to leverage diverse perspectives and expertise to drive innovation forward.

Conclusion:

Inventor Akos Szakmary's relentless commitment to innovation and patient care sets him apart as a pioneering figure in the field of stem cell transplantation. His patented methods not only offer new hope for patients in need of HSC therapies but also pave the way for safer and more effective treatment options in the future. As he continues his work at the University of California, Szakmary's contributions are poised to make a lasting impact on the realm of regenerative medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…